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~ Ageing end the Molecular  and St ructura l  
Remodelling of Cardiac Extracelluier Matrix During 
41-Admnerglc  St imulat ion 
S, M~seon, B, Aroslo, F, FIordaltBo, N, Gagllano, D, Snntnmbrogle, 
L, Calvllle, R. LalInL G, Anneal I~t/tuto "Mar/o N~gri" and IRCCS Osped.'ll~ 
Mapglom, Mt#ln, Italy 
~.tackgrolmd: The e[~poclly el the ngnd henri to adapt to work overload by 
compensatory responses la deb~ted, Ac~erdlngty, we compared the melee. 
ular trod t~Iructuml remodelling el the myocardial oxtmeollul~r matrlx of old 
~nd yoking r~Is In m~ponso to shert4orm infusion el a/I.~dmnerglo agontst, 
M#thexf~" M~lo Wlstal rats agnd 3. (young) or t8 months (old) were 
Inlus0d for ~1 d with t~oproterenol (ISO, 1 mg/kgld) by Impt¢lnted osmotic 
reinlpumps or untreated (centre1), The mRNA nbundemce of ANP, .,. (I) 
(COL.I) ~nd .1 (111) (COL.Ill) procollngens, TGF./It, TGF./13 and SPARC 
(~lecmted Protein Acidic and Rich in Cy~lelne, a glycoproteln with anti- 
adl~e~lvo propedte~) genes In LV wore evaluated by Northern and Dot blot 
ennly~e~ while collagen accum~llatlon in LV Intemlltlum and around coronary 
artndes wels measured with an atttomafod ireage analyzer alter ~inus md 
staining, 
R~sOIP&' I~O infusion rai~ad HFI by arotlnd 80 bpro ia oill~ol Voting ot old 
animals and provoked similar increase of LV wotgltt (+38% v~, +44% in young 
Velar, is old rats, 2.way ANf3VA'. N9 interaction), The messnnger ab~lndaece 
of ANP was increemod 2,fl and 2 1.fold by ISO in LV from young sad old rats, 
respectively, Transcripts el SPARC, COL.Ill, TGF~/II and TGF~II;~, hut hal 
COL4, Inero~nd ~Imllariy In each age group, Inlemtll!al collagnn dons(IV was 
t~Ignllicanfly higher In old than in young controls, bul It roached similar levels 
alter ISO infusion (4,8~ t 0,49 v,~, 4,8g t 0,46% el LV area), Ponvascular 
Iibropls increased independently ot age, 
Concloslon: LV from aged rata has prosonmd the capacity to adapt to 
sust~leed iI-admnorgic stlmultlllen by undergoing a process el remodelling • 
hypc,lrepl~ y and flbre~l,'~ • comparable to thai observed in youngm animals 
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~-3 j  Age-aaso©lated LV Remode l lng  In Normal  Men and 
Women Detected by 3D MRI 
P,& Hoes. J,L, Flog. J,L, Weiss. S,L, Bosloy, E,G, Lakatta. EP. Shapiro 
Joflna He.ins Una~rs~ff., and Gerontology Research Center, NIA, 
Bait/morn, MD, USA 
Ecl~ocardiogrepl~ic (echo) LV wall thickness increases with normative aging, 
suggesting global LV hypertrophy (LVH), However, autopsy studies have 
;~hown no change, oI an actual der.roaso, in LV mass wilh ago. especially 
=n men, To investigate this apparent discrepancy, we studied 3D strectural 
changes of the LV with aging using MRI, in 160 normal subiects (83 female 
l'~nd 77 male, ages 21-93) in the Baltimore Longitudinal Study of Aging, 
camtully screened for the absence of hypertension and corena~ disease. 
In each sublect, LV mass (M) was determined from a series of short axis 
slt~,.~ using Slmpson's rote, and LV apex-to-base Ionglh (L), regional wall 
thickness (WT), and diameter (D), were measured. Also, 2D-donved M.modo 
echo was used to measure WT and D in a random subset of 80 sublocts, 
and M derived by a standard ASE algorithm, L. WT, and D wore indexed to 
height, and mass to BSA, 
In women, MRI-WT increased by about 20°,;., over the ago range studied (r 
= 0,27, p ,  0,05) while MRI-L tended to decrease by about 9% (r = 0,19. p 
= 0.10), and MRI-D was unchanged (r .... O14. p = 0,25). As a result, MRI-M 
did not van with ago (r = 0,04, p = 0.06), In men. MRI-W'T and MRI-D wore 
unchanged (r = 0.04, p = 0,81: r = 009. p = 0,48. respectively), but there 
was an 9% tall in MRI-L (r = 0.33, p - 0004), resulting in a 12% decrease 
in MRI-M over the ago range studied (r = 0.25, p -: 0.04), Echo-M did not 
vary with age in either gender, although echo-Wl increased in both. 
Therefore, advancing ego is accompanied by a gender-dependent re, 
modeling of the LV, which, in women tends to shoden as the wall thickens, 
without a change in overall mass, but in men shortens without a change in 
wall thickness with reduced overall mass, The LV thus becomes more spher- 
ical with advancing age. Those changes, which require 3D data to detect, 
may contnbute to the reduced functional resenre in the elderly, 
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~--~ Quantitative Evaluation of Changes In Global  Left  
Ventrlcuier Shape Associated With Aging In the 
Absence of  Heart Disease 
G. Mirra, K. Ogunyankin, E. Avelar, D, Galzerano, D. Lama, M V~nnan, 
N. Pandian "ruffs • New ~n.clland Medical Center, Boston, MA. U,~'A 
It is known that aging is a.~sociated with preservation of end-diastolic volume 
as well as global systolic function, and a progressive increase in relative 
LV wall thickness, The effect of those on global LV shape in a normal 
elderly population is not known. We hypothesized that the LV In the aged 
undergoes remodeling to a more spherical I~hapo in order to presenre LV 
volume and function, Using 2D echo, we studied 19 eldedy subjects aged 
75 ;~: 8 yre (65-91) and 13 healthy subjects aged 28 .t 3 yre (24-3,2). None 
had significant head disease, hypertension, LVH, GHF or ¢oronnn/d!senso. 
The end-systolic (as) and end.diastolic fed) endecardinl ¢ontoum (aptcal 
LAX) view were dtglllzed and procos.~od oslng a proprietary Feuder she=pc_ 
analysl~ 8oftwaro, The Fourier Power [n~x (Pl) and the F3 ~rnpononl in 
end.diastole ~nd end.systole in the aged were comll~red to thief in Iilo young, 
Higher PI (onltloss) represents ~ morn ellipfien! vonldcle, while a lower value 
represents ~ more_ aphorle~! ventricle, The F3 component (unit!ass) i~ 
measure et elongation, nn index comactnd for ventfieglar ~i~e, 
R~uft,q; 
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Plod tfl ! t 06 r4~ I 133 001' 
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We coechlde that the LV goemot~/shows a mere roued shape deformatmn 
will~ tecroaslng ago in the absence of overt heart dtscose, and those changes 
are more proaouncod in systole. 
Special Topics In Acute Myocardial Infarction 
Therapy: Strokes and Calcium Channel 
Blockers 
Wednesday ,  Apri l  1, 1998,  4 :00  p,m,-5:00 p,m, 
Georg ia  Wor ld  Congress  Center ,  Room 261W 
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9~~ Comparison of  S t roke  Rates in Patients With Acute  
- -  Coronary  Syndromes  and  Pat ients With Acute  
Myocard ia l  In farc t ion  
K.W. Mahaffoy, R.A. Hamngton, C. Graffagnino. M J. Alberts. M A. Stoan. 
J.M. Miller, CB. Granger, ML  Simoons. E.J Topoi, RM. Calift Duke 
Clinical Research Institute. Durham. NC. USA 
l~tckgroUnd" The ask for stroke in patients with acute myo~ardlal tnta~cteon 
(MI) treated with thrembolysis is well characterized but the incidence m 
patients with unstable angln&~non-Q wave MI is less certain. 
Methods To compare the stroke rates in these two patient populabons we 
analyzed data hem GUSTO-I (N = 41,021 ) and data from the PURSUIT trial 
of 10,948 pationte evaluating low-dose (N = 1487l and high-dose (N = 4722) 
gtycoprotein liberia inhibition compared with placebo IN = 4739) in patients 
with unstable angina/non-Q wave MI. 
Stroke Type PURSUIT GUSTO-I 
Inllaccamal hemorrhage 3 (0 t%) 3 tO 1%) 268 tO 7%) 
Non-hemorrhagic 34107%l 27 tO 6%) 247 tO 6%) 
Results: The intracranial hemorrhage rate was low in the absence el 
thrombolylic therapy. The rates for non-hemonhagic stroke were similar 
despite patients tn PURSUIT being slightly older (median age. 64 vs 62). 
more otten female (35% vs 25%), and with a higher incidence of hypertension 
(55% vs 38%). prior MI (32% vs 16%). and pnor stroke or transient ischemic 
attack (4% vs 2%) corapared with the GUSTO-I population. 
Conclusion: Intrecranial hemorrhage is not increased with use of lib/Ilia 
inhibition, while nomhemorrhagic stroke is observed in patients across the 
entire spectrum of acute corona~ syndromes. 
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~2~ The Rat~ of Ischemic St roke  Fo l lowing Acute  
Myocardial Infarction Is Decreasing. The National 
Registry of  Myocard ia l  Infarct ion Exper ience  
MA Stoan. S.R Pirzada. J,P. Ornate, J.H. GunNitz. J.M. Gore, 
A.J. Tiefenbrunn, W.J. French. W,D. Weaver, W.J. Rogers. For the NRMI-2 
participants University of Maryland: Baltimore. Maryland, USA 
Background: Little descriptive information exists on the rate of and outcome 
from ischemic stroke (IS) following acute myocardial infarction (AMI) outside 
randomized clinical tdals. 
JACC Fehma~ I~)~ 4()7A 
~,~thods: AMI pabents presenting ~t 1529 US hospitals wero enrolled 
in tho National Rogistry of Myocardial Infa~ion (NRMI-2) from 7/1194 to 
12/31/96 IS was defim~ as a focal neurological deficit due to confirmod 
ischomi¢ brain infarction In unadiustod analyses, temporal trond~, m d=flor. 
enoL~ in rate of and ouIcomo from IS in pstients who d~l (T) or did not (NT) 
receive thrombolyttc therapy were so.~ght, 
Results: 0! 445,!48 NRMI-~ p~tte~ts. 130.6~9 (294%) received throm- 
b0~i¢ therapy. Them were 3950 (0,89%) IS ,~n age 71.5 yeats), IS 
rate w~ Sig~flCardty lo~r  in T I~lt~l~ts han in ~ patlen~ (overall 0.63% 
~.  1.00%, p ~ 0001; l~me pe~:  T.0~53% ~ 7-1~ VIL 0,75% from 
7-12/94o ~,  re~q~n; NT ,O,~ from 7-1~ v~, 114% from 7~1~,  
~% r~dt.l¢1~t; allp .: 0,001), IS-associated ~Otlalily was s~f¢'antlY lower 
in T I~l~ntS than in NT Ip~f l ts  (26.9% VS, ~14,~, p .~ O001)~ 
Cohort,s/OraL" The rat~ ot !,~ ~ ~ ~ad~,l!y and slgndmanlly 
over time m ~ T and NT patmms, The fining° Of reduced IS rate and 
IS~ssOO~ ated moffahty rate over time in T patients suggest a benefit 
ot thmmb~ therapy for AMI on !S wevent~n_ 
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~111e Relat!oeshiP ~ Calcium CWeel  
Rio°kin 90n~S and Mortality in A~ ~rd la l  
I n fa~ 
J G- Jofl¢s, RJ. Sm~son, W.E_ Casoo, J.R Crouse, MK Cl'tOw~u~, 
$C Sm~, Medial F~,w ol Nerth Car~ Ca~ NC, USA 
To further ~ r  the cocz~rovemy ~amrmg the retalKm between ca~cmm 
chan~ Uock~g drugs (CCSs) and mo~,  ~k~**ng acute myocard~a~ 
mfa~ (M|), we e~ammeO I year modatdy for 177.383 ekferty pahe~s 
according lo treatment w~h CCBs On cf~:harcje (HCFA's Coope~ Car- 
dm~ascubr ~ t~4-S).  The 57,822 ~ dL~-'hargml on CCBs (~m- 
azem 23.821, nded~me 14,162, amto0Tq3me 12.720, verapan'~i 4,040, other 
3,079) were shgt¢~y order, mote h~e~ to be women~ and have prim comna~ 
c~sease, hypettensto~ and non Q-~.~ myocardial infarctions. C~ I year 
mo~a~ty was foyer fo~ ~1 CCB types except bep~l  After risk adjustment 
(demographics_ contrary ~s ,e  and MI seventy, and con~rb~ dtness) ac- 
coring to a ipm~wts~, scorn, ip~ents treate~ with CCBs had k~wer 30 day 
lrelatn~ r~k 0.67 P - 0001) and 1 year mortahty ffefatwe risk 085 P • 
o 0os). 
t 2 3 4 5 
3~ ~,av CC~ 46 33 36 34 29 
moc'.~P,~ % ~ CCB 78 55 5 3 4 4 4 1 
I ~-~-3~ CCB 27 ~ 27 8 2~ 4 L ~) 1 30 3 
m.~t'tahtv % noCCB ,344 326 3~33 3.$2 345 
Thus, cont:ary to prev~ meta-a~a~/ses, we ta~lecl to find an association 
between calcium blocker therapy and mortality toflowmg acute Mi rn a large 
cohorl o! elderly patfents 
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~;arolovascurar Uu1¢omes In thQ ChOlesterol and 
Rocurmnt Eventm (CARE) Trial 
V, Papadememog. D Na~h. P, Narayan. B, Daws, L, $~mpson, G Mara~s, 
J~ Rouleau, F Sacks, Institute O~ CaK~ogte, H~rt~ Sct~ol ot Put~c 
Hea~, V,~: ~ Mec!~t Cem, v ,~,  OC., USA 
~gfound: .  Th~ Main tabu!Is of the CARE trial have been I~Vm~Sty 
I,~hed (NE=JM, 1996: 335: 101~9), The puq~oee of the present analysm was 
to assess the assoctatfon Of¢a~1¢i1~'~ cham';~t t~¢kef (CCB) t ~  w,~h 
otltcomes 
Methoo~ Ot the 4,159 paft~q~t~ofs, m~zed an av of 10 too, post MI, 
1,648 (39,6%) were treated at base!i~ w~ CCB (av age 59.0 ~ 92 Y~) 
& 2,5!1 were not (No CCB ~ age 58.4 ~_ 9,4 Yl~S), C0mpanson.s betwee~ 
gfo~ were made using ¢ht sq.. unwanate & muflwanate a~lysm, 
Results: At baseline pls On CCB had h~= ~VEF (54,1 vs 52.3%, p - 
00001), tetal ChOI (2096 v~ 20?.8 m~*dt; p 0 001), LDL,C (139.2 vs 1382 
mgtdl, p = 0.03), Hx of hyperlensm~ (49.1% vs 384%; p < 00001), ¢~etes 
metlltus 116.3 v'S t2,7%1 p ~ 00011. & Hx o1 PTCA (36(~ vs 21.7%; p < 
0,001 ), Fewer pts On CCB had Hs of CABG ( 12.0% vs 27 I~;  p < 00011, H~ 
0f CHF (5,7% vs 80%,~ p - 0.004). treatment with ACE Inhibltc,~ (11 6% vs 
16 3%; p ~ 0.001 ) o,z beta blockers (32.0% vs 45 5%, p ~ 0.001). Pravastatm 
therapy resulted In s~gndcant reduct~n of total choL & LDL cholesterol m bo~h 
groups but reductions were greater in the CCB group. At the end of the fo~k~ 
up penod after con~mlhng to, basehne d~terervces, patmnts on CCB had 55% 
h~]her incKlerme of PTCA (p ~ O.00t), 82% more CABG (p < 0.001), 64% 
more tmstabte arena (p ~: 0.001). 30% more CVS hospital=zatmns (p
0.0001) & 2.04 times the risk d GI bleed (p = o018). 
C ~ :  Use of CCBs is a marker of high nsk of recurrent card=ovas- 
cutar events in pts w~th acute MI 
